NIH Official Advocates for MAHA Strategy at ADA Conference Amid Skepticism
During the American Diabetes Association conference, a senior NIH advisor presented the MAHA strategy, asserting its alignment with the agency's priorities, despite some skepticism from attendees.
Editorial Staff
1 min read
Updated 4 days ago
A senior official from the National Institutes of Health (NIH) recently addressed researchers at the American Diabetes Association (ADA) conference, promoting the MAHA strategy.
The advisor emphasized that the goals of the MAHA initiative correspond with the NIH's priorities, aiming to foster collaboration and innovation in diabetes research.
However, the reception to this strategy was mixed, with some attendees expressing skepticism regarding its feasibility and effectiveness in addressing current challenges in diabetes care.